There has been increasing interest in the use of circulating DNA as biomarkers for various tissue injuries, cancers, and fetal conditions. DNA methylation is a well-characterized mechanism underlying the epigenetic regulation of gene expression, and many diagnostic tests based on DNA methylation patterns have been developed. We developed a novel TaqMan-based assay for the detection of acute kidney injury using a hypomethylated promoter region of Slc22a12, a urate transporter specifically expressed in proximal tubular cells. Bisulfite sequencing analysis confirmed that the CpG islands in the promoter region of mouse Slc22a12 were preferentially hypomethylated in the kidney cortex. TaqMan minor groove binder (MGB) probes reliably discriminated the DNA fragments corresponding to the unmethylated and methylated promoter regions of Slc22a12. Plasma levels of unmethylated DNA corresponding to the Slc22a12 promoter region were undetectable at baseline and were significantly elevated after acute kidney cortex necrosis. This study showed the usefulness of the TaqMan system in discriminating methylated and unmethylated DNA fragments, and the similar strategy can be applied for establishing biomarkers for various cellular injuries or pathological conditions.
There has been increasing interest in the use of circulating plasma nucleic acids as biomarkers for various diseases (5) . Recent reports have described the effectiveness of using various cell-specific microRNAs in detecting cellular injuries such as myocardial (13) and cerebral infarctions (23) . DNA sequencing of plasma cell-free DNA has been recently applied in prenatal aneuploidy screening (19) . Epigenetic methylation patterns of plasma cell-free DNA have also been utilized in the diagnosis of various cancers (4) . DNA methylation is a well-characterized mechanism underlying the epigenetic regulation of gene expression (1, 21) . Methylation of cytosine residues in CpG dinucleotides negatively regulates gene transcription through the recruitment of chromatin remodeling factors, and several reports (17, 24) have highlighted the key role of DNA methylation in tissue-or cell-specific gene transcription. For example, the mouse insulin-2 gene (Ins2) promoter has three potential methylation (CpG) sites, all of which are unmethylated in insulin-producing cells but are methylated in other tissues (16) . Utilizing these cellspecific DNA methylation patterns, Husseiny et al. developed a quantitative, methylation-specific polymerase chain reaction (PCR) assay for monitoring beta cell death by streptozotocin (11) . They utilized methylation-specific primers to detect DNA fragments corresponding to methylated and unmethylated Ins2 promoters. The purpose of the present study was to establish a biomarker for kidney injury utilizing a kidney-specific DNA methylation pattern. The expression of urate transporter 1 (Slc22a12) is restricted to the This study was conducted in accordance with the guidelines of the National Cerebral and Cardiovascular Center for the Care and Use of Experimental Animals and the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Adequate measures were taken to minimize the pain and discomfort in animals.
DNA isolation and bisulfite sequencing. DNA was extracted from tissues using a DNeasy Blood & Tissue Kit (QIAGEN, Valencia, CA), according to the manufacturers' instructions. Plasma DNA was extracted from the tissues using NucleoSpin Plasma XS (Macherey-Nagel, Düren, Germany), following the manufacturers' instructions. The extracted DNAs were bisulfite-converted using a MethylEdge™ Bisulfite Conversion System (Promega, Madison, WI), following the manufacturer's recommendations. A 553-bp fragment of mouse Slc22a12, which harbored eight CpG sites, was PCR-amplified from the bisulfite-converted DNA using primer sets PCR 1-F/1-R and PCR 2-F/2-R (Table 1) with EpiTaq HS DNA polymerase (TAKARA, Shiga, Japan), according to the manufacturer's instructions. The PCR product was cloned into the pTA2 vector using a TArget clone™ Plus cloning kit (TOYOBO, Osaka, Japan). The DNA sequencing was performed on a Genetic Analyzer 3130 (Applied Biosystems, Foster City, CA) to confirm the cloned sequence by using the M13F and M13R primers.
Development of a real-time quantitative PCR assay
for the unmethylated DNA. To validate the assay system, promoter region DNAs corresponding to unproximal tubules of the kidney, where it is responsible for the tubular reabsorption of urate (6, 20, 18) . Kikuchi et al. showed that the proximal promoter region of Slc22a12 was hypermethylated in the liver and kidney medulla, whereas this region was relatively hypomethylated in the kidney cortex (14) . Thus, the promoter region of mouse Slc22a12 might be an excellent candidate for our purpose. Moreover, we tried to utilize a refined TaqMan detection system for discriminating DNAs corresponding to methylated and unmethylated promoter regions of Slc22a12 instead of a quantitative PCR assay using methylation-specific primers.
MATERIALS AND METHODS
Animal treatment. Male C57BL/6J mice were housed in a temperature-controlled room on a 12-h light/12-h dark cycle. They were fed with mouse chow (Oriental Yeast, Tokyo, Japan) and provided with tap water ad libitum. Mouse tissue samples (i.e., brain, heart, kidney, and liver) were resected for DNA isolation. Acute kidney injury (AKI) was induced in the mice by contact-freezing the kidney surface with dry ice (3). Venous blood sample was collected into ethylenediaminetetraacetic acid (EDTA)-containing vials for DNA measurement and into heparin-containing vials for aspartate aminotransferase (AST) measurement at 6 h after the contact freezing or sham operation (n = 6, each group). Plasma was isolated by centrifugation at 1600 × g for 15 min at 4°C. Plasma AST concentrations were measured with an automatic analyzer (DRI-Chem 7000Z; FUJIFILM, Tokyo, Japan). ated DNA in the plasma was estimated using the TaqMan MGB system described above, based on the analytical curve of the positive control plasmid. The validity of the entire procedure was separately confirmed with a real-time quantitative PCR assay of the reference DNA.
Statistical analysis. Data are presented as mean ± SD. Statistical analysis was performed by using the Student's t-test implemented in the JMP statistical analysis package (SAS Institute, NC, USA).
RESULTS

Methylation patterns of Slc22a12 promoter
Eight CpG dinucleotides existed within the 5'-flanking sequence of Slc22a12 up to position −500; seven of these were within the minimal promoter region ( Fig. 1 ) (14) . Bisulfite sequencing was performed using the DNAs isolated from the kidney cortex, kidney medulla, liver, left ventricle, and brain (Fig. 2) . The CpGs were heavily methylated in the kidney medulla, liver, left ventricle, and brain, whereas these sites were approximately 50% unmethylated in the kidney cortex, where Slc22a12 was preferentially expressed in tubular cells.
Validation of the real-time quantitative PCR assay for the unmethylated DNA
The TaqMan MGB probe was designed to discrimimethylated (as a positive control) and methylated (as a negative control) types of Slc22a12 were subcloned into a pTA2 vector and were used as assay templates. The unmethylated and methylated DNAspecific (tubular cell-specific) TaqMan minor groove binder (MGB) probe (Table 1) were designed to detect an unmethylated and methylated cytosine at position −153, respectively. Quantitative unmethylation-specific PCR was performed with a 7500 RealTime PCR System (Applied Biosystems). Each 20 μL of reaction mixture contained 15-25 ng of bisulfitetreated DNA as a template, 10 μL of Universal MasterMix (Applied Biosystems), 100 nM of TaqMan MGB probe, and 400 nM each of the forward and reverse primers (Primer F/R: Table 1 ). Thermal cycling was initiated with an enzyme activation step of 10 min at 95°C, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. In addition, we confirmed the validity of the entire procedure using a synthetic DNA as an internal control (reference DNA, Table 1 ).
Real-time quantitative PCR assay for the unmethylated DNA in plasma samples.
Prior to plasma DNA isolation, 40 amol of the reference DNA was added to 200 μL of plasma as an internal reference to validate the procedure, including DNA purification, bisulfite conversion, and recovery. DNA isolated from 200 μL of the plasma was resuspended in 20 μL of DNase-free water. The concentration of unmethyl- 
isolating the cells with Laser microdissection (data not shown).
Real-time quantitative PCR assay for the unmethylated DNA in plasma samples AKI was induced in mice by contact-freezing with dry ice. A significant rise of plasma AST and visual inspection at sacrifice confirmed induction of cortex necrosis (Fig. 4A) . The plasma levels of DNA corresponding to the unmethylated Slc22a12 promoter were undetectable at baseline, while they were significantly elevated 6 h after the freezing with dry ice (Fig. 4B) . Furthermore, the plasma levels of unmeth- nate the CpG at position −153 of the promoter region. The discriminative performance of the TaqMan MGB probes were assessed using known amounts of positive/negative control DNAs derived from plasmids (Fig. 3A, B) . The TaqMan MGB probe did not show a signal in the negative control DNA, and another probe showed the same result. This assay system facilitated the assessment of DNA methylation patterns in various mouse tissues and reconfirmed that this CpG was predominantly unmethylated in the kidney cortex (Fig. 3C) . Furthermore, we confirmed that approximately 80% of Slc22a12 DNA was unmethylated in the proximal tubular cells by ylated Slc22a12 DNA were correlated (r 2 = 0.7555, P < 0.05) to plasma AST levels (Fig. 4C) .
DISCUSSION
The present study confirmed that the DNA methylation patterns of proximal tubular cells could be utilized for establishing biomarkers for kidney injuries. This is the first study to utilize the TaqMan system for discriminating circulating DNAs corresponding to methylated and unmethylated CpGs for biomarker purpose. Besides Slc22a12, various other SLC family transporters were predominantly expressed in the kidney. Slc22a6 and Slc22a8 are considered to mediate tubular secretion and/or the reabsorption process in the kidney (8) . Slc6a9, Slc6a20, Slc7a8, and Slc7a9 are considered to mediate the renal reabsorption of amino acids filtered from the blood circulation through the glomeruli and into the urine (2). The methylation statuses of these transporters in the kidney, as compared with those in the liver, were reported previously. Jin et al. reported that Slc22a6 and Slc22a8 were relatively hypomethylated in the kidney cortex in the mouse (12) . Kikuchi et al. also showed that Slc6a9, Slc6a20, Slc7a8, and Slc7a9 were relatively hypomethylated in the kidney as compared with the liver (15) . However, our preliminary study showed that the promoter methylation pattern of Slc22a12 showed most highly tissue-specific pattern, and was the best for our purpose, and we selected Slc22a12 in the present study. We used TaqMan MGB probes to develop an unmethylation-specific PCR assay for AKI. By using an in vitro model based on synthetic DNA, we were able to detect nucleotides in blood at concentrations as low as 0.1 amol/μL (Fig. 3D) . In general, mouse blood contains 10 7 nucleated cells/mL (7), and a 25-g mouse has a total blood volume of approximately 2 mL (22) , indicating that the assay could highly likely to be improved in future studies as various cells continuously undergo cell-specific and/ or disease-specific DNA methylation patterns. Intriguingly, our preliminary study indicated that, by using cell-free urine DNA, this TaqMan MGB probe system for detection of unmethylated Slc22a12 was able to detect the acute tubular necrosis induced by gentamycin or cisplatin. REFERENCES detect DNA obtained from 10 5 cells distributed throughout the blood volume of the mouse (9, 10) . On the other hand, Husseiny et al. developed a quantitative methylation-specific PCR assay for beta cell death using SYBR Green real-time PCR (11) . The TaqMan MGB probe system is supposed to be superior to SYBR Green system in terms of sensitivity and specificity. However, several issues relating to this assay need to be resolved before it can be fully applied to actual screening tests. First, this assay involves numerous steps, including DNA isolation from plasma, bisulfite conversion, and a TaqMan real-time PCR assay. Although the specificity could be improved by selecting the assay sites containing several CpGs, sensitivity might be a problem because of the relatively high background of the TaqMan MGB system caused by heating-induced probe degradation. Despite these aforementioned drawbacks, this method offers a broad range of applications and is 
